Meningitis B Vaccine (Bexsero) is now available
The charge per child, for 1 course of treatment is £320 for 2 vaccines including administration and consultation fee. Babies 9 months or under require 2, rather than 1, boosters.
There are 5 types of Bacterial (meningococcal) Meningitis: A,B,C,W,Y B (MenB) is a type of meningitis, a disease which causes the layer covering the brain and spinal cord to become infected and swollen. It can also cause septicaemia (blood poisoning) which is a very dangerous illness. The symptoms of MenB develop very quickly and it can kill within 24 hours.
A separate combination vaccine is available against A,C,W and Y.
Possible side effects:
In infants and children (less than 2 years of age) the most common local and systemic adverse reactions observed in clinical trials were tenderness and erythema at the injection site, fever and irritability.
Bexsero may cause fever in infants for about a day, more commonly when it is co-administered with other routine childhood vaccinations. In the second year of life, fever reactions did not appear to be increased when Bexsero was given with a combination vaccine against measles, mumps, rubella and varicella (MMRV).
Bexsero follows a 3 dose schedule for infants 2-5 months, and a 2 dose schedule at all ages 6 months and over. Bexsero can therefore be given alongside other routine infant vaccinations without any additional visits being required.
Bexsero can also be used to vaccinate adolescents to address the secondary peak in the incidence of MenB which occurs in the mid-to-late teens. In addition to providing direct protection for adolescents, Bexsero may help to address long-term disease control.